Swissmedic announced the publication of its 2016 Annual Report. During the year, the agency: • approved 42 medicinal products with new active substances for the Swiss market — a 50% increase compared to 2015 • received a total of 12,678 applications, completed 12,933, and by the end of 2016, 8,417 medicinal products were approved for the Swiss market (734 of these were veterinary) • performed 65 inspections of manufacturers and wholesalers, and • agreed to intensify collaboration with two partner authorities abroad, the UK’s Medicinal and Health Products Regulatory Authority (MHRA), and Mexico’s Federal Commission for Protection against Sanitary Risk (COFEPRIS).
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
